Simulations Plus Inc.
NASDAQ:SLP 4:00:00 PM EDT
| Market Cap (Intraday) | 350.94M |
| Current PE | 48.34 |
| Forward PE | 18.56 |
| 2yr Forward PE | 16.31 |
| 10-Day MA | $18.37 |
| 50-Day MA | $28.17 |
| 200-Day MA | $29.81 |
Simulations Plus Inc. Stock, NASDAQ:SLP
800 Park Offices Drive, Suite 401, Durham, North Carolina 27709
United States of America
Phone: +1.661.723.7723
Number of Employees: 247
Description
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.